多隻醫療器械股逆市續升 心通(02160.HK)及微創(00853.HK)漲近8%-11%
恆指今早反覆跌278點至16,308再創11年低位喘定,午後跌幅曾收窄至僅32點,現報16,508,回吐79點或0.5%,總成交額651億元。
醫療器械板塊今日以微創醫療(00853.HK)表現最好,股價由逾半年低位連升第四天,今天股價重越50天線(16.09元)最高見17.46元,現報17元,逆升10.5%,成交連續第二天維持活躍已達3,004萬股,涉資4.94億元。微創醫療附屬微創蹤影本月初獲8名投資者注資合共2億人民幣。完成後,微創醫療於微創蹤影持股將由86%攤薄至68.8%。
心通醫療-B(02160.HK)兩連升,最高見2.58元(暫受制50天線2.6元),現報2.49元,續升7.8%。啟明醫療-B(02500.HK)由上市低位連彈第二天,最高見9.8元, 現報9.61元,續彈2.6%。貝康醫療-B(02170.HK)高見3.2元,現報3.06,續彈3%。康基醫療(09997.HK)五連升,最高見6.16元,現報6元,續升1.9%。華檢醫療(01931.HK)及華潤醫療(01515.HK)兩連升,報2.05元及4.3元,續升2%及2.4%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.